Exelon prices $900 million convertible senior notes offering

Exelon priced a $900 million offering of convertible senior notes due March 15, 2029, at a 3.25% fixed rate (interest semiannual beginning Sept. 15, 2026) with an initial purchaser option for an additional $100 million; net proceeds are estimated at ~$888.8 million ($987.5 million if the option is exercised) to be used for debt repayment/refinancing and general corporate purposes. Notes convert initially at 17.5093 shares per $1,000 principal (conversion price ~$57.11, a 25% premium to Monday's close), with limited conversion prior to Dec. 15, 2028 and full conversion thereafter; Exelon’s debt-to-equity is ~1.78 and market cap ~$46.17 billion. The company also reported Q3 2025 EPS of $0.86 versus $0.78 expected and revenue of $6.71 billion versus $6.48 billion expected, and disclosed senior leadership changes and a temporary employee plan blackout tied to a vendor transition.

Analysis

Market structure: The $900M 3.25% convertible (plus $100M option) supplies cheap hybrid capital to EXC, immediately reducing near-term cash refinancing pressure (net proceeds ≈ $888.8M) and benefiting credit investors who get an equity kicker. The conversion price of $57.11 (≈25% premium to close) makes near-term equity dilution unlikely unless EXC rallies >25%, so bondholders and the company are primary winners while equity holders face a low-probability long‑term overhang. Cross‑asset: expect modest tightening in EXC credit spreads vs. utility peers, slight downward pressure on implied equity volatility, and limited direct FX/commodity impact beyond power-market hedges.

Risk assessment: Tail risks include adverse regulatory rate-case outcomes (material to utility cash flows), a hawkish interest‑rate shock that re-prices EXC’s broader $~50B debt burden, and operational shocks (large plant outages). Timeline: immediate (days) — transaction pricing and secondary market reaction; short (weeks–months) — debt rollover and liquidity metrics improve; long (2028–2029) — conversion window opens (post‑Dec 15, 2028) creating dilution/overhang risk. Hidden dependencies: pension liabilities, wholesale power exposure and state-level rate decisions; catalysts include Fed moves, major rate cases, or a >25% stock rally.

Trade implications: Direct—establish a tactical 2–3% long position in EXC (ticker EXC) targeting $57 by 12–36 months with a hard stop at $40 (≈‑12–15% from today); institutional—participate in the 2029 convertible allocation at issuance for 1–2% of credit portfolio if execution yield is at least +75bp vs. comparable 5‑yr utility IG bonds. Options—buy 12‑month protective puts at $40 (cap cost) or buy a Jan 2027 50/60 call spread size 1–2% NAV to play gradual rerating; pair trade—long EXC vs. short NEE (dollar‑neutral) for 12–24 months to play regulated vs. growth dispersion.

Key Decisions for Investors

• Establish a tactical 2–3% long position in EXC equity (ticker EXC), target price $57.11 within 12–36 months, place a stop-loss at $40 (cut position if breach persists beyond 3 trading days).
• For institutions with 144A access, allocate 1–2% of credit portfolio to the new EXC 2029 convertible if pricing yields at least +75bp over comparable 5-year utility IG bonds or an OAS advantage ≥75bp; rebalance if conversion implied probability rises above 30%.
• Implement options overlay: buy 12-month protective puts at $40 for 0.5–1% NAV or buy a Jan 2027 50/60 call spread (size 1–2% NAV) to capture upside to conversion price with defined risk; close spreads if EXC > $57 or volatility collapses >40% from issuance levels.
• Initiate a dollar-neutral pair trade: long EXC vs short NEE (NextEra) for 12–24 months (equal dollar exposure), scaling into position over 2–6 weeks; trim long EXC if regulatory rate-case outcomes are negative in IL/NJ/PA or if EXC stock closes >$57 for 10 consecutive sessions.